This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Histiocytosis Haematophagic
Information about Histiocytosis Haematophagic: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Histiocytosis Haematophagic
Most recent studies have shown that Histiocytosis Haematophagic shares some biological mechanisms with anemia, blood-coagulation-disorders, epstein-barr-virus-infections, histiocytosis, histiocytosis-non-langerhans-cell, infective-disorder, leukemia, liver-dysfunction, lymphohistiocytosis-hemophagocytic, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, pancytopenia, t-cell-lymphoma, virus-diseases.
Among the many pathways, these few ones have gauged particular interests from scientists studying Histiocytosis Haematophagic, and have been seen in publications frequently: Cell Activation, Cell Proliferation, Coagulation, Cytokine Secretion, Cytolysis, Exocytosis, Glycosylation, Hypersensitivity, Immune Response, Inflammatory Response, Killer Activity, Macrophage Activation, Parturition, Pathogenesis, Phagocytosis, Secretion, T Cell Activation, T Cell Proliferation, Tropism, Virus-host Interaction
Quite a number of genes have been found to play important roles in Histiocytosis Haematophagic, such as AP3B1, CD4, CD68, CD8A, CRP, CTLA4, HLA-DQA1, HPS1, IFNG, IL10, IL2, IL6, KRT20, LYZ, MS4A1, NOD2, SH2D1A, SLC25A10, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.